CNSide® is a more sensitive and definitive test for LM and has the potential to permit earlier diagnosis, manage our patients with more diagnostic precision, and hopefully improve therapeutic outcomes for our patients with LM.

I just want to share that this is amazing!

This drop in [my patient’s] CSF CTCs also correlates with her clinical status after treatment, and she is so happy to see the numbers drop so much. This is exactly why we need this assay: to be able to quantify the patient’s disease so we know if they are responding to treatments or not. As you know, CSF cytology is a simple yes vs. no and therefore not very helpful, as it doesn’t tell us if the disease is responding to treatment or not, not to mention the sensitivity of CSF cytology is so low that it doesn’t always give us an accurate answer.